|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wycislo KL and Fan TM: The immunotherapy
of canine osteosarcoma: A historical and systematic review. J Vet
Intern Med. 29:759–769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morris CD, Teot LA, Bernstein ML, Marina
N, Krailo MD, Villaluna D, Janeway KA, DuBois SG, Gorlick RG and
Randall RL: Assessment of extent of surgical resection of primary
high-grade osteosarcoma by treating institutions: A report from the
children's oncology group. J Surg Oncol. 113:351–354. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xie X, Li YS, Xiao WF, Deng ZH, He HB, Liu
Q and Luo W: MicroRNA-379 inhibits the proliferation, migration and
invasion of human osteosarcoma cells by targetting EIF4G2. Biosci
Rep. 37:BSR201605422017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, He Z, Li Y, Yang Y, Shi J, Liu X,
Yuan T, Xia J, Li D, Zhang J and Yang Z: Selection of surgical
methods in the treatment of upper tibia osteosarcoma and prognostic
analysis. Oncol Res Treat. 40:528–532. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee JA, Paik EK, Seo J, Kim DH, Lim JS,
Yoo JY and Kim MS: Radiotherapy and gemcitabine-docetaxel
chemotherapy in children and adolescents with unresectable
recurrent or refractory osteosarcoma. Jpn J Clin Oncol. 46:138–143.
2016.
|
|
7
|
Ferrari S and Serra M: An update on
chemotherapy for osteosarcoma. Expert Opin Pharmacother.
16:2727–2736. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.
|
|
9
|
Adamopoulos C, Gargalionis AN, Basdra EK
and Papavassiliou AG: Deciphering signaling networks in
osteosarcoma pathobiology. Exp Biol Med (Maywood). 241:1296–1305.
2016. View Article : Google Scholar
|
|
10
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tehrani SS, Karimian A, Parsian H,
Majidinia M and Yousefi B: Multiple functions of long non-coding
RNAs in oxidative stress, DNA damage response and cancer
progression. J Cell Biochem. 119:223–236. 2018. View Article : Google Scholar
|
|
12
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ju C, Zhou R, Sun J, Zhang F, Tang X, Chen
KK, Zhao J, Lan X, Lin S, Zhang Z and Lv XB: LncRNA SNHG5 promotes
the progression of osteosarcoma by sponging the miR-212-3p/SGK3
axis. Cancer Cell Int. 18:1412018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang R, Liu Y, Liu H, Chen W, Fan HN,
Zhang J and Zhu JS: The long non-coding RNA SNHG12 promotes gastric
cancer by activating the phosphatidylinositol 3-kinase/AKT pathway.
Aging (Albany NY). 11:10902–10922. 2019. View Article : Google Scholar
|
|
15
|
Xia P, Liu P, Fu Q, Liu C, Luo Q, Zhang X,
Cheng L, Qin T and Zhang H: Long noncoding RNA EPIC1 interacts with
YAP1 to regulate the cell cycle and promote the growth of
pancreatic cancer cells. Biochem Biophys Res Commun. 522:978–985.
2020. View Article : Google Scholar
|
|
16
|
Ding H, Luo Y, Hu K, Liu P and Xiong M:
Linc00467 promotes lung adenocarcinoma proliferation via sponging
miR-20b-5p to activate CCND1 expression. Onco Targets Ther.
12:6733–6743. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li GC, Xin L, Wang YS and Chen Y: Long
intervening noncoding 00467 RNA contributes to tumorigenesis by
acting as a competing endogenous RNA against miR-107 in cervical
cancer cells. Am J Pathol. 189:2293–2310. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Majid S, Dar AA, Saini S, Yamamura S,
Hirata H, Tanaka Y, Deng G and Dahiya R: MicroRNA-205-directed
transcriptional activation of tumor suppressor genes in prostate
cancer. Cancer. 116:5637–5649. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Z, Chen J, Xie H, Liu T, Chen Y, Ma
Z, Pei X, Yang W and Li L: Androgen receptor suppresses prostate
cancer metastasis but promotes bladder cancer metastasis via
differentially altering miRNA525-5p/SLPI-mediated vasculogenic
mimicry formation. Cancer Lett. 473:118–129. 2020. View Article : Google Scholar
|
|
21
|
Chen J, Wu Z and Zhang Y: LncRNA SNHG3
promotes cell growth by sponging miR-196a-5p and indicates the poor
survival in osteosarcoma. Int J Immunopathol Pharmacol.
33:20587384188207432019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li G and Zhu Y: Effect of lncRNA ANRIL
knockdown on proliferation and cisplatin chemoresistance of
osteosarcoma cells in vitro. Pathol Res Pract. 215:931–938. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Su P, Mu S and Wang Z: Long noncoding RNA
SNHG16 promotes osteosarcoma cells migration and invasion via
sponging miRNA-340. DNA Cell Biol. 38:170–175. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu B, Zhao H, Zhang L and Shi X:
Silencing of long-non-coding RNA ANCR suppresses the migration and
invasion of osteosarcoma cells by activating the p38MAPK signalling
pathway. BMC Cancer. 19:11122019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song K, Yuan X, Li G, Ma M and Sun J: Long
noncoding RNA CASC11 promotes osteosarcoma metastasis by
suppressing degradation of snail mRNA. Am J Cancer Res. 9:300–311.
2019.PubMed/NCBI
|
|
26
|
Li Z, Liu J, Chen H, Zhang Y, Shi H, Huang
L, Tao J, Shen R and Wang T: Ferritin light chain (FTL) competes
with long noncoding RNA Linc00467 for miR-133b binding site to
regulate chemoresistance and metastasis of colorectal cancer.
Carcinogenesis. 41:467–477. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang W, Cheng X, Wang T, Song X, Zheng Y
and Wang L: LINC00467 promotes cell proliferation and metastasis by
binding with IGF2BP3 to enhance the mRNA stability of TRAF5 in
hepatocellular carcinoma. J Gene Med. 22:e31342020. View Article : Google Scholar
|
|
28
|
D'Angelo B, Benedetti E, Cimini A and
Giordano A: MicroRNAs: A puzzling tool in cancer diagnostics and
therapy. Anticancer Res. 36:5571–5575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Srivastava SK, Bhardwaj A, Leavesley SJ,
Grizzle WE, Singh S and Singh AP: MicroRNAs as potential clinical
biomarkers: Emerging approaches for their detection. Biotech
Histochem. 88:373–387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cui Y, Yi L, Zhao JZ and Jiang YG: Long
noncoding RNA HOXA11-AS functions as miRNA sponge to promote the
glioma tumorigenesis through targeting miR-140-5p. DNA Cell Biol.
36:822–828. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li T, Meng XL and Yang WQ: Long noncoding
RNA PVT1 Acts as a 'sponge' to inhibit microRNA-152 in gastric
cancer cells. Dig Dis Sci. 62:3021–3028. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu H, Xu Y, Zhang D and Liu G: Long
noncoding RNA LUCAT1 promotes malignancy of ovarian cancer through
regulation of miR-612/HOXA13 pathway. Biochem Biophys Res Commun.
503:2095–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Long B, Li N, Xu XX, Li XX, Xu XJ, Liu JY
and Wu ZH: Long noncoding RNA LOXL1-AS1 regulates prostate cancer
cell proliferation and cell cycle progression through miR-541-3p
and CCND1. Biochem Biophys Res Commun. 505:561–568. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang B, Zhu SJ, Xiao SS and Xue M:
MiR-217 inhibits M2-like macrophage polarization by suppressing
secretion of inter-leukin-6 in ovarian cancer. Inflammation.
42:1517–1529. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yin Z and Ren W: MicroRNA-217 acts as a
tumor suppressor and correlates with the chemoresistance of
cervical carcinoma to cisplatin. Onco Targets Ther. 12:759–771.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen G, Yang Z, Feng M and Wang Z:
microRNA-217 suppressed epithelial-to-mesenchymal transition
through targeting PTPN14 in gastric cancer. Biosci Rep.
40:BSR201931762020. View Article : Google Scholar :
|
|
37
|
Zhu L, Yang S and Wang J: miR-217 inhibits
the migration and invasion of HeLa cells through modulating MAPK1.
Int J Mol Med. 44:1824–1832. 2019.PubMed/NCBI
|
|
38
|
Yang J, Lu C, Wei J, Guo Y, Liu W, Luo L,
Fisch G and Li X: Inhibition of KPNA4 attenuates prostate cancer
metastasis. Oncogene. 36:2868–2878. 2017. View Article : Google Scholar :
|
|
39
|
Li X, Yu M and Yang C: YY1-mediated
overexpression of long noncoding RNA MCM3AP-AS1 accelerates
angiogenesis and progression in lung cancer by targeting
miR-340-5p/KPNA4 axis. J Cell Biochem. 121:2258–2267. 2020.
View Article : Google Scholar
|
|
40
|
Zhang M, Luo H and Hui L: MiR-3619-5p
hampers proliferation and cisplatin resistance in cutaneous
squamous-cell carcinoma via KPNA4. Biochem Biophys Res Commun.
513:419–425. 2019. View Article : Google Scholar : PubMed/NCBI
|
